Cipleumab 40 mg Injection consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

FAQs

How does Cipleumab 40 mg Injection work?

Cipleumab 40 mg Injection contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.

Who should not take Cipleumab 40 mg Injection?

Cipleumab 40 mg Injection affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Cipleumab 40 mg Injection can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.